Abstract
ADVERTISEMENT RETURN TO ISSUEPREVLetterNEXT3-[2-(Pyrrolidin-1-yl)ethyl]indoles and 3-[3-(Piperidin-1-yl)propyl]indoles: Agonists for the h5-HT1D Receptor with High Selectivity over the h5-HT1B SubtypeJosé L. Castro, Leslie J. Street, Alexander R. Guiblin, Richard A. Jelley, Michael G. N. Russell, Francine Sternfeld, Margaret S. Beer, Josephine A. Stanton, and Victor G. MatassaView Author Information Chemistry and Biochemistry Departments, Merck Sharp and Dohme Research Laboratories, Neuroscience Research Centre, Terlings Park, Eastwick Road, Harlow, Essex CM20 2QR, U.K. Cite this: J. Med. Chem. 1997, 40, 22, 3497–3500Publication Date (Web):October 24, 1997Publication History Received14 July 1997Published online24 October 1997Published inissue 1 October 1997https://doi.org/10.1021/jm9704558Copyright © 1997 American Chemical SocietyRIGHTS & PERMISSIONSArticle Views507Altmetric-Citations13LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InReddit Read OnlinePDF (137 KB) Get e-AlertsSupporting Info (1)»Supporting Information Supporting Information SUBJECTS:Agonists,Piperidines,Pyrrolidines,Receptors,Selectivity Get e-Alerts
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
